LAURA MEIER: Open Payments
NPI 1407409857 · CARLISLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,398 in 71 payments from 9 companies in 2025. Trend: 2023 $617 · 2024 $843 · 2025 $1,398
Food & beverage: $1,321Education: $77
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 33 | $600 |
| ABBVIE INC. | 24 | $451 |
| Gilead Sciences, Inc. | 1 | $118 |
| Celltrion USA Inc. | 3 | $67 |
| PFIZER INC. | 3 | $49 |
| Ardelyx, Inc. | 2 | $43 |
| Phathom Pharmaceuticals, Inc. | 3 | $36 |
| Novo Nordisk Inc | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: TREMFYA, RINVOQ, Livdelzi, CREON, VEGZELMA, VELSIPITY, IBSRELA, MAVYRET.
Industry payments across PA — which companies pay providers there.
